DogStem RSS Authorised This medicine is authorised for use in the European Union equine umbilical cord-derived mesenchymal stem cells Medicine Veterinary Authorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on DogStem Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine DogStem Active substance equine umbilical cord-derived mesenchymal stem cells International non-proprietary name (INN) or common name equine umbilical cord-derived mesenchymal stem cells Pharmacotherapeutic groupOther drugs for disorders of the musculo-skeletal system Authorisation details EMA product number EMEA/V/C/005829 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for DogStemAdopted Reference Number: EMA/CVMP/576246/2022 English (EN) (124.62 KB - PDF)First published: 17/06/2022 View News on DogStem Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 May 202516/05/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-15 June 202217/06/2022 This page was last updated on 08/02/2024 Share this page